Interestingly, ABLIM1 has been previously reported to be down-regulated and act as a candidate tumor suppressor in glioblastoma [21] and melanoma [22], whereas its expression pattern and role remain unknown in colorectal cancers. Here, ABLIM1 is linked to colorectal cancer.